Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2023;34(4):506-12
Article Links
Cachexia Prevalence in a Population of Moroccan Women with Rheumatoid Arthritis
Hamza Toufik1, Najlae El Ouardi1, Mohamed Ahmed Ghassem1, Julien H. Djossou1, Laila Taoubane1, Abderrahim Majjad1, Abdellah El Maghraoui2, Ahmed Bezza1
Authors Information

¹Rheumatology Department, Military Hospital Mohammed V, Rabat, Morocco

²Cabinet of Rheumatology, Rabat, Morocco

El Ouardi N, Ghassem MA, Djossou JH, El Maghraoui A

Keywords: rheumatoid arthritis, body composition, rheumatoid cachexia, fat mass, fat-free mass, dual-energy x-ray absorptiometry
References
  1. Kerola AM, Kerola T, Kauppi MJ, Kautiainen H, Virta LJ, Puolakka K. Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2013 Nov;72(11):1826-9.
  2. Kyle UG, Genton L, Pichard C. Body composition: what’s new? Curr Opin Clin Nutr Metab Care 2002 Jul;5(4):427-33.
  3. Wang ZM, Pierson RNJ, Heymsfield SB. The five-level model: a new approach to organizing body-composition research. Am J Clin Nutr 1992 Jul;56(1):19-28.
  4. Paget J. Clinical Lectures: ON THE NERVOUS MIMICRY OF ORGANIC DISEASES,. Lancet [Internet] 1873 Nov 22;102(2621):727-9. Available from: https://doi.org/10.1016/S0140-6736(02)69188-3
  5. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol 2002 Sep;85(1):89-99.
  6. Elkan AC, Håkansson N, Frostegård J, Cederholm T, Hafström I. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a crosssectional study. Arthritis Res Ther 2009;11:R37.
  7. Florea VG, Moon J, Pennell DJ, Doehner W, Coats AJ, Anker SD. Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. Int J Cardiol 2004;97:15-20.
  8. Ogata-Medel M, Llorente L, Hinojosa-Azaola A, Lozada-Mellado M, Pineda-Juarez JA, et al. Cachexia measured by bioelectrical impedance vector analysis and risk of infection in women with rheumatoid arthritis. Clin Rheumatol 2023 Feb;42(2):391-7. doi: 10.1007/s10067-022-06431-5. Epub 2022 Nov 14. PMID: 36372851; PMCID: PMC9660131.
  9. Challal S, Minichiello E, Boissier M-C, Semerano L. Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes. Joint Bone Spine 2016 Mar;83(2):127-33.
  10. Elkan A-C, Engvall I-L, Tengstrand B, Cederholm T, Hafström I. Malnutrition in women with rheumatoid arthritis is not revealed by clinical anthropometrical measurements or nutritional evaluation tools. Eur J Clin Nutr 2008 Oct;62(10):1239-47.
  11. Elkan A-C, Engvall I-L, Cederholm T, Hafström I. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 2009 Aug;48(5):315-22.
  12. Pødenphant J, Gotfredsen A, Engelhart M, Andersen V, Heitmann BL, Kondrup J. Comparison of body composition by dual energy X-ray absorptiometry to other estimates of body composition during weight loss in obese patients with rheumatoid arthritis. Scand J Clin Lab Invest 1996 Nov;56(7):615-25.
  13. Toombs RJ, Ducher G, Shepherd JA, De Souza MJ. The impact of recent technological advances on the trueness and precision of DXA to assess body composition. Obesity (Silver Spring) 2012 Jan;20(1):30-9.
  14. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994 Jun;93(6):2379-86.
  15. Santo RCE, Fernandes KZ, Lora PS, Filippin LI, Xavier RM. Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2018 Oct;9(5):816-25.
  16. Schutz Y, Kyle UUG, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord J Int Assoc Study Obes 2002 Jul;26(7):953-60.
  17. El Maghraoui A, Sadni S, Rezqi A, Bezza A, Achemlal L, Mounach A. Does Rheumatoid Cachexia Predispose Patients with Rheumatoid Arthritis to Osteoporosis and Vertebral Fractures? J Rheumatol 2015 Sep;42(9):1556-62.
  18. Hugo M, Mehsen-Cetre N, Pierreisnard A, Schaeverbeke T, Gin H, Rigalleau V. Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis: an observational study using calorimetry and actimetry. Rheumatology (Oxford) 2016 Jul;55(7):1202-9.
  19. Engvall I-L, Elkan A-C, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol 2008;37(5):321-8.
  20. Wolfe F, Michaud K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012 Oct;64(10):1471-9.
  21. Chen Y-M, Chen H-H, Hsieh C-W, Hsieh T-Y, Lan J-L, Chen D-Y. A close association of body cell mass loss with disease activity and disability in Chinese patients with rheumatoid arthritis. Clinics (Sao Paulo) 2011;66(7):1217-22.
  22. Konijn NPC, Van Tuyl LHD, Bultink IEM, Lems WF, Earthman CP, Van Bokhorst-De Van Der Schueren MAE. Making the invisible visible: Bioelectrical impedance analysis demonstrates unfavourable body composition in rheumatoid arthritis patients in clinical practice. Scand J Rheumatol 2014;43(4):273-8.
  23. Lombard LA, du Plessis LM, Visser J. Body composition of rheumatoid arthritis patients in the City of Cape Town, South Africa. Clin Rheumatol 2014 Apr;33(4):467-76.
  24. Santillán-Díaz C, Ramírez-Sánchez N, Espinosa-Morales R, Orea-Tejeda A, Llorente L, Rodríguez-Guevara G. Prevalence of rheumatoid cachexia assessed by bioelectrical impedance vector analysis and its relation with physical function. Clin Rheumatol 2018 Mar;37(3):607-14.
  25. Morley JE, Thomas DR, Wilson M-MG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006 Apr;83(4):735-43.
  26. Alvarez-Nemegyei J, Buenfil-Rello FA, Pacheco-Pantoja EL. Association between body composition and disease activity in rheumatoid arthritis. A systematic review. Reumatol Clin 2016;12(4):190-5.
  27. Seelaender M, Laviano A, Busquets S, Püschel GP, Margaria T, Batista MLJ. Inflammation in Cachexia. Mediators Inflamm 2015;2015:536954.
  28. Walsmith J, Abad L, Kehayias J, Roubenoff R. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 2004 Jan;31(1):23-9.
  29. Lemmey AB, Wilkinson TJ, Clayton RJ, Sheikh F, Whale J, Jones HSJ. Tight control of disease activity fails to improve body composition or physical function in rheumatoid arthritis patients. Rheumatology (Oxford) 2016 Oct;55(10):1736-45.
  30. Baker JF, Cannon GW, Ibrahim S, Haroldsen C, Caplan L, Mikuls TR. Predictors of longterm changes in body mass index in rheumatoid arthritis. J Rheumatol 2015 Jun;42(6):920-7.
  31. Metsios G, Stavropoulos-Kalinoglou A, Douglas K, Koutedakis Y, Nevill A, Panoulas V. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) 2007 Dec 1;46:1824-7.
  32. Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006 Dec;84(6):1463-72.